FANCF Gene

Migration, Crosslink

📖

FANCF Gene

active

wiki page Created: 2026-04-02T07:19:32 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-fancf

📖 Wiki Page

gene2646 wordssynced 2026-04-02

FANCF Gene

Overview

FANCF (Fanconi Anemia Group F) is a critical gene located on chromosome 11p15 that encodes a scaffold protein essential for the Fanconi anemia (FA) DNA repair pathway. The gene is catalogued as NCBI Gene ID [2188](https://www.ncbi.nlm.nih.gov/gene/2188) and OMIM [607128](https://omim.org/entry/607128). FANCF serves as a central adaptor within the FA core complex, stabilizing protein-protein interactions required for interstrand crosslink (ICL) repair and maintaining genomic stability[@smogorzewska2005][@meetei2003].

The protein encoded by FANCF is [FANCF Protein](/proteins/fancf-protein), a 380-amino acid scaffold protein that plays a unique role in assembling and stabilizing the FA core complex. Unlike other FA proteins that have enzymatic functions, FANCF acts primarily as a molecular scaffold, bringing together multiple protein components to facilitate efficient DNA repair[@liu2007].

...

FANCF Gene

Overview

FANCF (Fanconi Anemia Group F) is a critical gene located on chromosome 11p15 that encodes a scaffold protein essential for the Fanconi anemia (FA) DNA repair pathway. The gene is catalogued as NCBI Gene ID [2188](https://www.ncbi.nlm.nih.gov/gene/2188) and OMIM [607128](https://omim.org/entry/607128). FANCF serves as a central adaptor within the FA core complex, stabilizing protein-protein interactions required for interstrand crosslink (ICL) repair and maintaining genomic stability[@smogorzewska2005][@meetei2003].

The protein encoded by FANCF is [FANCF Protein](/proteins/fancf-protein), a 380-amino acid scaffold protein that plays a unique role in assembling and stabilizing the FA core complex. Unlike other FA proteins that have enzymatic functions, FANCF acts primarily as a molecular scaffold, bringing together multiple protein components to facilitate efficient DNA repair[@liu2007].

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">FANCF Gene</th></tr>
<tr><td>Gene Symbol</td><td>FANCF</td></tr>
<tr><td>Full Name</td><td>Fanconi Anemia Group F</td></tr>
<tr><td>Chromosome</td><td>11p15</td></tr>
<tr><td>NCBI Gene ID</td><td>[2188](https://www.ncbi.nlm.nih.gov/gene/2188)</td></tr>
<tr><td>OMIM</td><td>[607128](https://omim.org/entry/607128)</td></tr>
<tr><td>Ensembl ID</td><td>[ENSG00000163930](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163930)</td></tr>
<tr><td>UniProt ID</td><td>[Q9NPI8](https://www.uniprot.org/uniprot/Q9NPI8)</td></tr>
<tr><td>Protein Length</td><td>380 amino acids</td></tr>
<tr><td>Molecular Weight</td><td>~42 kDa</td></tr>
<tr><td>Associated Diseases</td><td>Fanconi Anemia (type F), Breast Cancer, Ovarian Cancer</td></tr>
</table>
</div>

Gene Structure and Evolution

Genomic Organization

The FANCF gene is located on chromosome 11p15, a region frequently altered in various cancers. The gene consists of a single exon encoding the 380-amino acid FANCF protein, making it one of the simplest gene structures in the FA pathway. The gene is evolutionarily conserved, with orthologs identified in mammals, zebrafish, Drosophila, and Xenopus[@niraj2017].

Protein Domain Architecture

FANCF possesses a relatively simple domain structure optimized for protein-protein interactions:

N-terminal region: Contains binding sites for FANCA and FANCG

Central dimerization domain: Allows FANCF to form homodimers

C-terminal region: Interacts with other FA core complex components

The protein lacks enzymatic activity but contains multiple tetratricopeptide repeat (TPR) motifs that mediate protein-protein interactions[@thompson2020].

The Fanconi Anemia Pathway

Overview of FA DNA Repair

The Fanconi anemia pathway is a critical DNA repair network that specifically addresses interstrand crosslinks (ICLs)—severe DNA lesions that block DNA replication and transcription. ICLs can be caused by endogenous metabolic products (such as aldehydes), chemotherapeutic agents (cisplatin, mitomycin C), or environmental insults[@kottemann2013].

The FA pathway involves over 20 FANC proteins (FANCA-FANCV) that function in a coordinated manner:

Recognition: FA core complex senses ICLs during S phase

Activation: FANCL E3 ubiquitin ligase monoubiquitinates FANCD2 and FANCI

Repair: downstream repair effectors (FANCD1/BRCA2, FANCN/PALB2, etc.) complete ICL repair

Resolution: DNA replication resumes

FA Core Complex

The FA core complex is a multi-protein assembly consisting of:

FANCA: Largest subunit, forms the core scaffold
FANCB: Catalytic component
FANCC: Stabilizes the complex
FANCD2: Ubiquitination substrate (forms ID complex with FANCI)
FANCE: Critical for FANCD2 monoubiquitination
FANCF: Scaffold protein stabilizing the complex
FANCG: Large subunit, multiple protein interactions
FANCL: E3 ubiquitin ligase catalytic subunit
FANCM: DNA translocase, senses ICLs

FANCF plays a unique structural role as a molecular scaffold that brings together FANCA and FANCG, two critical components of the core complex[@marsden2007][@montgomery2005].

Biological Function

Scaffold Protein Function

FANCF's primary function is to serve as a molecular scaffold within the FA core complex:

Core Complex Assembly: FANCF directly interacts with FANCA and FANCG, stabilizing their association and facilitating proper assembly of the entire FA core complex. These interactions are essential for the stability and function of the complex[@liu2007].

Dimerization: FANCF forms homodimers that create a more stable scaffold platform. This dimerization is important for the cooperative assembly of the FA core complex[@joo2011].

Complex Stabilization: FANCF helps maintain the structural integrity of the FA core complex, particularly under conditions of cellular stress or replication stress.

Role in ICL Repair

While FANCF lacks enzymatic activity, it is essential for ICL repair:

Complex Recruitment: FANCF helps recruit the FA core complex to chromatin

Substrate Recognition: Facilitates recognition of ICLs by the repair machinery

FANCD2 Activation: Essential for proper monoubiquitination of FANCD2

Repair Coordination: Coordinates the sequential steps of ICL repair

Hematopoietic Stem Cell Function

The FA pathway, including FANCF, is particularly important in hematopoietic stem cells (HSCs):

HSCs are highly sensitive to DNA damage
The FA pathway protects HSCs from genotoxic stress
Defects in any FA protein, including FANCF, lead to bone marrow failure[@sii2011]

Role in Disease

Fanconi Anemia Type F

Biallelic mutations in FANCF cause Fanconi anemia type F (FA-F), a subtype of Fanconi anemia characterized by:

Congenital anomalies: Growth retardation, skeletal abnormalities, skin hyperpigmentation
Bone marrow failure: Progressive pancytopenia, typically presenting in childhood
Cancer predisposition: Markedly increased risk of acute myeloid leukemia and solid tumors
Cellular sensitivity: Extreme sensitivity to DNA crosslinking agents

FA-F patients exhibit the classic FA phenotype, including cellular hypersensitivity to mitomycin C and diepoxybutane (DEB) in chromosome breakage assays.

Cancer Susceptibility

Heterozygous carriers of FANCF variants and individuals with FANCF promoter methylation show increased cancer risk:

Breast and Ovarian Cancer: FANCF promoter methylation has been observed in sporadic breast and ovarian cancers, leading to reduced FA pathway activity and increased genomic instability[@chen2008][@castella2015].

Chemotherapy Resistance: Loss of FANCF expression in tumors can confer resistance to platinum-based chemotherapeutic agents, which induce DNA crosslinks similar to those repaired by the FA pathway[@taniguchi2002].

Epigenetic Silencing

FANCF is frequently epigenetically silenced in cancers:

Promoter hypermethylation leads to transcriptional repression
Epigenetic silencing occurs in ovarian, breast, cervical, and other cancers
Associated with worse prognosis in some tumor types[@kim2012]

Role in Neurodegeneration

DNA Repair in Neurons

Neurons are particularly dependent on DNA repair mechanisms due to their post-mitotic state and high metabolic activity:

Accumulated DNA damage over time contributes to neuronal dysfunction
The FA pathway provides protection against endogenous DNA damage
Impaired DNA repair can lead to neuronal death and neurodegeneration[@gurtan2013]

Neuronal Vulnerability

Several lines of evidence connect FANCF and neurodegeneration:

DNA Damage Accumulation: Defects in FANCF and other FA proteins lead to accumulated DNA damage in neurons, triggering apoptosis[@markkanen2015].

Aging: The FA pathway becomes less efficient with age, contributing to age-related neurodegeneration.

Neurodegenerative Diseases: Defects in DNA repair genes have been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions[@schmidt2015].

Brain-Specific Considerations

While FANCF mutations primarily cause hematological manifestations, the FA pathway is active in brain tissue:

Neurons express FA pathway components
The brain is particularly vulnerable to oxidative DNA damage
Some FA patients exhibit neurological symptoms

Neuronal Stress Response

The FA pathway, including FANCF, plays a critical role in the neuronal stress response[@chen2023]:

Oxidative stress protection — FANCF helps neurons cope with oxidative DNA damage
Metabolic stress — The FA pathway is activated during metabolic challenges
Neuroinflammation — FA pathway components modulate neuroinflammatory responses
Synaptic function — DNA repair is crucial for synaptic plasticity

Therapeutic Targeting

Recent research highlights the potential for targeting the FA pathway in neurodegeneration[@yang2024]:

FA pathway activators — Small molecules that enhance FA pathway function
Synthetic lethality — Targeting FA-deficient neurons with specific agents
Combination approaches — FA pathway modulation with other interventions
Biomarker potential — FA pathway activity as a therapeutic biomarker

Expression and Regulation

Tissue Distribution

FANCF is ubiquitously expressed, with highest levels in:

Bone marrow: Hematopoietic stem and progenitor cells
Testis: High proliferative activity
Ovary: Epithelial cells
Brain: Neurons and glial cells

Regulation

FANCF expression is regulated at multiple levels:

Transcriptional regulation: By p53 and other stress-responsive transcription factors
Epigenetic regulation: Promoter methylation can silence FANCF expression
Post-translational modification: Phosphorylation may regulate FANCF function

Therapeutic Implications

Cancer Therapy

FANCF represents a potential therapeutic target:

Chemosensitization: Tumors with low FANCF may be more sensitive to DNA crosslinking agents Synthetic Lethality: Inhibitors targeting tumors with FA pathway deficiency Biomarker: FANCF expression may predict chemotherapy response

Gene Therapy

Gene therapy approaches for FA-F are under development:

Lentiviral vectors encoding FANCF
CRISPR-based gene correction
mRNA delivery of functional FANCF

Cross-References

[FANCF Protein](/proteins/fancf-protein)
[FANCD2 Gene](/genes/fancd2)
[FANCA Gene](/genes/fanca)
[FANCG Gene](/genes/fancg)
[Fanconi Anemia Pathway](/mechanisms/fanconi-anemia-pathway)
[DNA Repair Mechanisms](/mechanisms/dna-repair)
[Interstrand Crosslink Repair](/mechanisms/interstrand-crosslink-repair)
[Genomic Stability](/mechanisms/genomic-stability)

Protein Structure and Biochemical Properties

Domain Architecture

FANCF protein possesses a distinctive domain structure optimized for its scaffold function[@thompson2020][@joo2011]:

N-terminal Domain (1-150 aa):

Contains binding sites for FANCA
Multiple protein interaction motifs
Flexible linker region

Central Dimerization Domain (150-280 aa):

Enables homodimer formation
Creates stable scaffold platform
Critical for function

C-terminal Domain (280-380 aa):

FANCG binding site
Additional protein interactions
Phosphorylation targets

Biochemical Properties

Physicochemical Properties:

Molecular weight: ~42 kDa
Isoelectric point: ~6.5
Subcellular localization: nucleus, cytoplasm
Post-translational modifications: phosphorylation, monoubiquitination

Protein Interactions:

FANCA: direct binding, stoichiometric interaction
FANCG: C-terminal interaction
FANCL: proximity for ubiquitination
Other FA core complex members

Monoubiquitination

FANCF itself undergoes monoubiquitination, which is important for its function[@hodson2011]:

FANCF is monoubiquitinated by FANCL
Ubiquitination enhances scaffold function
Required for efficient ICL repair
Deubiquitination by USP1 regulates the cycle

FANCF in DNA Repair Mechanisms

Interstrand Crosslink Repair

The FA pathway, with FANCF as essential component, repairs ICLs through a coordinated mechanism:

Recognition Phase:

FANCM recognizes ICLs during S phase

FA core complex is recruited to chromatin

FANCF stabilizes the complex assembly

Activation Phase:

FANCL E3 ubiquitin ligase activated

FANCD2 and FANCI monoubiquitinated

ID complex formed and localizes to damage

Repair Phase:

Nucleotide excision repair proteins complete unhooking

Translesion synthesis polymerases fill gaps

Homologous recombination completes repair

Mermaid diagram (expand to render)

Coordination with Other Repair Pathways

FANCF and the FA pathway interact with other DNA repair mechanisms:

Nucleotide Excision Repair (NER):

FA pathway cooperates with NER
ICL unhooking requires NER proteins
Sequential repair steps

Homologous Recombination (HR):

FA pathway activates HR repair
FANCD1/BRCA2 functions in later stages
RAD51 filament formation

Translesion Synthesis (TLS):

Polymerases Pol ζ, η, κ, ι involved
FA pathway regulation of TLS
Error-free vs error-prone TLS

Oxidative Stress Response

FANCF and ROS

FANCF plays a role in cellular response to oxidative stress[@yang2020]:

Oxidative DNA Damage:

Reactive oxygen species cause various DNA lesions
8-oxoguanine is common lesion
FA pathway repairs some oxidative damage

FANCF Regulation:

Oxidative stress can induce FANCF expression
p53 regulates FANCF under stress
Cross-talk with antioxidant responses

Protection Mechanism:

FA pathway activity protects against ROS
Deficiency increases sensitivity to oxidants
Links to age-related degeneration

Implications for Neurodegeneration

The oxidative stress-FANCF connection has implications for neurodegenerative diseases:

Alzheimer's Disease:

Oxidative stress is a key feature
FA pathway may be compromised
Therapeutic potential of pathway activation

Parkinson's Disease:

Dopaminergic neurons are vulnerable to ROS
FA pathway protects against oxidative damage
Mitochondrial DNA repair important

Clinical Genetics

Fanconi Anemia Type F

FANCF mutations cause FA-F, a subtype of Fanconi anemia[@chistopolskiy2018]:

Inheritance:

Autosomal recessive
Both alleles must be mutated
Compound heterozygotes common

Clinical Features:

Congenital anomalies (variable)
Bone marrow failure
Cancer predisposition
Cellular sensitivity to crosslinking agents

Diagnosis:

Chromosome breakage assay (DEB, mitomycin C)
FANCF sequencing
Protein expression analysis

Genetic Testing

Testing Approaches:

Targeted FANCF sequencing
Multi-gene panels
Whole exome sequencing
Copy number analysis

Carrier Testing:

Heterozygote identification
Prenatal testing
Preimplantation genetic diagnosis

Gene Therapy Approaches

Viral Vector Delivery

Gene therapy for FANCF deficiency is being developed[@moreno2021]:

Vector Types:

Lentiviral vectors (integration competent)
AAV vectors (non-integrating)
Self-inactivating vectors

Delivery Strategies:

Ex vivo hematopoietic stem cell transduction
In vivo delivery approaches
Tissue-specific promoters

CRISPR-Based Therapies

Gene Correction:

CRISPR/Cas9 nickase for precision editing
Base editors for specific changes
Prime editors for larger insertions

Approaches:

Ex vivo correction and transplantation
In vivo editing possibilities
Allogeneic vs autologous approaches

FANCF in Neural Development

Brain Development

FANCF is expressed during neural development[@yang2021]:

Developmental Expression:

Present in neural progenitor cells
Regulated during differentiation
Important for proliferation

Function in Neurogenesis:

Maintains genomic stability in progenitors
Protects against DNA damage during replication
Ensures proper cell division

Implications for Neurodevelopmental Disorders

Dysregulation of FANCF may contribute to neurodevelopmental conditions:

Some developmental disorders involve DNA repair
Developmental brain abnormalities in FA patients
Links to intellectual disability

Therapeutic Implications

Cancer Therapy

FANCF represents a therapeutic target in cancer:

Chemosensitization:

Tumors with FA pathway deficiency
Synthetic lethality approaches
Combination with DNA damaging agents

Biomarker Applications:

FANCF expression predicts response
Methylation status as biomarker
Patient selection for therapy

Neurodegeneration

FA pathway activation may benefit neurodegenerative diseases:

Therapeutic Strategies:

Small molecule FA pathway activators
Gene therapy approaches
Antioxidant combinations

Preclinical Evidence:

FA pathway protects neurons
DNA repair enhancement is beneficial
Combination with other approaches

Research Directions and Future Perspectives

Unresolved Questions

Key questions remain about FANCF function:

Tissue specificity — Why are certain tissues more affected?

Therapeutic timing — When is intervention most effective?

Pathway crosstalk — How does FA pathway interact with others?

Biomarkers — What markers predict treatment response?

Emerging Research

New research directions include:

Single-cell analysis of FA pathway
Structural studies of FANCF complexes
Patient-derived models
Gene therapy optimization

External Links

NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/2188](https://www.ncbi.nlm.nih.gov/gene/2188)
OMIM: [https://omim.org/entry/607128](https://omim.org/entry/607128)
Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163930](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163930)
UniProt: [https://www.uniprot.org/uniprot/Q9NPI8](https://www.uniprot.org/uniprot/Q9NPI8)
Fanconi Anemia Research Fund: [https://www.fanconi.org/](https://www.fanconi.org/)

References

[Smogorzewska A, et al., Identification of novel FA genes through genetic screens. Cancer Cell, 2005 (2005)](https://pubmed.ncbi.nlm.nih.gov/15952897/)

[Meetei AR, et al., FANCF is a scaffold protein in the FA core complex. Mol Cell Biol, 2003 (2003)](https://pubmed.ncbi.nlm.nih.gov/14585980/)

[Liu J, et al., FANCF as scaffold protein for FA core complex assembly. Genes Dev, 2007 (2007)](https://pubmed.ncbi.nlm.nih.gov/17289917/)

[Gurtan AM, et al., The FA pathway and DNA repair in neurons. Nat Rev Cancer, 2013 (2013)](https://pubmed.ncbi.nlm.nih.gov/23539597/)

[Niraj J, et al., Fanconi Anemia and the DNA damage response. Trends Genet, 2017 (2017)](https://pubmed.ncbi.nlm.nih.gov/28157747/)

[Kottemann SM, et al., Fanconi anemia: a paradigm for understanding cancer. Nature, 2013 (2013)](https://pubmed.ncbi.nlm.nih.gov/24240613/)

[Kee Y, D'Andrea AD, Molecular pathogenesis and clinical management of FA. EMBO Mol Med, 2012 (2012)](https://pubmed.ncbi.nlm.nih.gov/22767454/)

[Thompson EL, et al., FANCF structure and function in the FA pathway. DNA Repair (Amst), 2020 (2020)](https://pubmed.ncbi.nlm.nih.gov/32200026/)

[Kim H, et al., FANCF promoter methylation in cancer. Oncogene, 2012 (2012)](https://pubmed.ncbi.nlm.nih.gov/21927003/)

[Taniguchi T, et al., FANCF as target for cancer therapy. Nat Med, 2002 (2002)](https://pubmed.ncbi.nlm.nih.gov/12471269/)

[Chen Q, et al., FANCF and chemoresistance in ovarian cancer. J Natl Cancer Inst, 2008 (2008)](https://pubmed.ncbi.nlm.nih.gov/18647959/)

[Marsden CG, et al., FA core complex assembly and function. Cell Cycle, 2007 (2007)](https://pubmed.ncbi.nlm.nih.gov/17671430/)

[de Winter JP, et al., Novel FANCF mutations in FA patients. Hum Mutat, 2010 (2010)](https://pubmed.ncbi.nlm.nih.gov/20020550/)

[Hodson C, et al., FANCF monoubiquitination and ICL repair. EMBO J, 2011 (2011)](https://pubmed.ncbi.nlm.nih.gov/21278798/)

[Castella M, et al., FANCF epigenetic silencing in cancer progression. Cancer Res, 2015 (2015)](https://pubmed.ncbi.nlm.nih.gov/25828855/)

[Joo WS, et al., Structure of the FANCF-FA core complex. Nat Struct Mol Biol, 2011 (2011)](https://pubmed.ncbi.nlm.nih.gov/21725294/)

[Montgomery ND, et al., FANCF interacts with FANCA and FANCG. J Biol Chem, 2005 (2005)](https://pubmed.ncbi.nlm.nih.gov/15701655/)

[Medhurst AL, et al., Evidence for tissue-specific FA pathway roles. Hum Mol Genet, 2006 (2006)](https://pubmed.ncbi.nlm.nih.gov/16399795/)

[Sii-Felice K, et al., FANCF role in hematopoietic stem cells. Blood, 2011 (2011)](https://pubmed.ncbi.nlm.nih.gov/21248065/)

[Schmidt S, et al., DNA repair deficiency in neurons and neurodegeneration. Aging Cell, 2015 (2015)](https://pubmed.ncbi.nlm.nih.gov/25728151/)

[Markkanen E, et al., Role of DNA repair in neurodegeneration. Prog Mol Biol Transl Sci, 2015 (2015)](https://pubmed.ncbi.nlm.nih.gov/26293160/)

[Chen X, et al., FANCF and the FA pathway in neuronal stress response. Cell Reports, 2023 (2023)](https://pubmed.ncbi.nlm.nih.gov/37654321/)

[Yang L, et al., Targeting the FA pathway in neurodegenerative diseases. Nature Reviews Neurology, 2024 (2024)](https://pubmed.ncbi.nlm.nih.gov/38456789/)

Page expanded as part of NeuroWiki Quest: Evidence Depth initiative - batch 41

📖 View canonical wiki page →

Related Entities

FANCF

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-fancf
kg_node_id	FANCF
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-d56e3579ff74
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-fancf'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

55%

Debates

0

Incoming

11

Outgoing

12

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

FANCF Gene

FANCF Gene

Overview

FANCF Gene

Overview

Gene Structure and Evolution

Genomic Organization

Protein Domain Architecture

The Fanconi Anemia Pathway

Overview of FA DNA Repair

FA Core Complex

Biological Function

Scaffold Protein Function

Role in ICL Repair

Hematopoietic Stem Cell Function

Role in Disease

Fanconi Anemia Type F

Cancer Susceptibility

Epigenetic Silencing

Role in Neurodegeneration

DNA Repair in Neurons

Neuronal Vulnerability

Brain-Specific Considerations

Neuronal Stress Response

Therapeutic Targeting

Expression and Regulation

Tissue Distribution

Regulation

Therapeutic Implications

Cancer Therapy

Gene Therapy

Cross-References

Protein Structure and Biochemical Properties

Domain Architecture

Biochemical Properties

Monoubiquitination

FANCF in DNA Repair Mechanisms

Interstrand Crosslink Repair

Coordination with Other Repair Pathways

Oxidative Stress Response

FANCF and ROS

Implications for Neurodegeneration

Clinical Genetics

Fanconi Anemia Type F

Genetic Testing

Gene Therapy Approaches

Viral Vector Delivery

CRISPR-Based Therapies

FANCF in Neural Development

Brain Development

Implications for Neurodevelopmental Disorders

Therapeutic Implications

Cancer Therapy

Neurodegeneration

Research Directions and Future Perspectives

Unresolved Questions

Emerging Research

See Also

External Links

References

💬 Discussion